Hbw Advisory Services LLC Regeneron Pharmaceuticals, Inc. Transaction History

Hbw Advisory Services LLC

  • $649 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 14, 2020
SELL
$544.75 - $658.21 $205,370 - $248,145
-377 Closed
0 $0
Q2 2020

Jul 08, 2020
SELL
$493.32 - $643.92 $29,105 - $37,991
-59 Reduced 13.53%
377 $235,000
Q1 2020

Apr 30, 2020
SELL
$336.18 - $494.43 $39,669 - $58,342
-118 Reduced 21.3%
436 $213,000
Q4 2019

Jan 16, 2020
BUY
$274.13 - $376.51 $151,868 - $208,586
554 New
554 $208,000

Others Institutions Holding REGN

# of Institutions
1,485
Shares Held
84.8M
Call Options Held
1.51M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hbw Advisory Services LLC Portfolio

Follow Hbw Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbw Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbw Advisory Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email